TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has provided an announcement.
Kilitch Drugs (India) Limited has announced a public notice regarding its 8th Annual General Meeting and e-voting information. This announcement is part of a broader context of financial and regulatory updates affecting the market, including rising government bond yields due to fiscal concerns and regulatory changes in India’s derivatives market. The bond market is experiencing pressure due to fiscal slippage worries and a lack of buyers, while the Securities and Exchange Board of India’s plans to extend derivative contract tenures could impact market liquidity. These developments reflect ongoing adjustments in the financial sector, which stakeholders should monitor closely.
More about Kilitch Drugs (India) Limited
Average Trading Volume: 3,293
Technical Sentiment Signal: Buy
Current Market Cap: 6.77B INR
Find detailed analytics on KILITCH stock on TipRanks’ Stock Analysis page.